Summary
CME Group Inc. (CME) has filed an 8-K report on October 23, 2024, announcing its financial results for the quarter ended September 30, 2024. The filing incorporates by reference a press release (Exhibit 99.1) detailing these results. A key aspect of the report is the presentation of both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures, including non-GAAP net income and earnings per share. Management utilizes these non-GAAP measures to offer supplemental insights into the company's financial performance and business trends, aiming to enhance comparability with prior periods. While these non-GAAP figures are presented as a supplement, the company emphasizes that they should be considered alongside, and not as a replacement for, the GAAP-based financial statements. A reconciliation of the non-GAAP measures to their most directly comparable GAAP counterparts is provided within the press release, in compliance with Regulation G.
Key Highlights
- 1CME Group Inc. reported its Q3 2024 financial results on October 23, 2024, via an 8-K filing.
- 2The filing includes a press release detailing the financial results for the quarter ended September 30, 2024.
- 3Both GAAP and non-GAAP financial measures are presented in the accompanying press release.
- 4Non-GAAP net income and earnings per share are provided as supplemental information.
- 5Management believes non-GAAP measures offer better comparability with prior financial reports and provide insights into business trends.
- 6Reconciliation of non-GAAP to GAAP measures is included in the press release as per Regulation G requirements.
- 7The information is incorporated by reference from Exhibit 99.1, the press release dated October 23, 2024.